期刊文献+

反相高效液相色谱法测定人血浆中奥美拉唑的浓度 被引量:2

Determination of omeprazole in plasma by RP-HPLC
暂未订购
导出
摘要 目的建立测定奥美拉唑血药浓度的反相高效液相色谱法,考察样品提取及色谱分离条件。方法血浆中加入内标尼美舒利后,用以乙醚提取,进行高效液相色谱法检测。以Dikma Technologies C18柱,甲醇:水:三乙胺:冰醋酸(60:40:0.5:0.5)为流动相进行色谱分离。流速1.0ml/min,检测波长302nm。结果奥美拉唑浓度在50—1800ng/ml范围内线性良好,r=0.9995。测定浓度为15、100、1500ng/ml的血浆样品,其日间及日内的RSD分别为0.86%、6.7%、4.93%和3.04%、4.25%、5.22%(n=5)。3种浓度的提取回收率分别为77.74%、79.44%和86.30%。结论方法简便、准确、灵敏,可用于奥美拉唑血药浓度的测定。 Objective A reversed-phase high performance liquid chromatography (RP-HPLC) was used to dertermine the concentration of omeprazole in human plasma. Meanwhile the sample extraction and chromatography isocation condition were examined. Methods After adding the internal standard nimesulide, the plasma samples were extracted with ethyl ether and determined by HPLC. Waters instrument was used with the column of Dikma Diamonsil C18 (200mm × 4.6mm,5μm). The mobile phase was compound of methanol-water-triethylamine-glacial acetic acid(60:40:0.5:0.5,V/V). How rate was 1.0ml/min. Results The omeprazole was quantitated using a ultraviolet detector operated at 302nm which allowed determinater at 5 - 1 800ng/ml of omeprazole with high reproduciblicity (r = 0. 9995). The with-inday and between-day precision(RSD) of the concentration(15,100,1 500ng/ml) were 0.86% ,6.7% ,4.93% and 3.04% ,4.25% ,5.22%(n = 5)%, respectively. The recoveries of omeprazole were 92.21% - 105.3% for plasma. Conclusion The RP-HPLC method is simple, rapid and sensitive, It is applicable to determine the concentration of omeprazole in huaman plasma.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2006年第2期170-172,共3页 Journal of Harbin Medical University
关键词 奥美拉唑 反相高效液相色谱法 血药浓度 omeprazole RP-HPLC plasma concentration of drug
  • 相关文献

参考文献6

二级参考文献3

共引文献38

同被引文献13

  • 1陈少波,吴定国.高效液相色谱法测定健康人血浆中奥美拉唑的浓度[J].医药导报,2006,25(10):999-1000. 被引量:2
  • 2霍保方,邱枫,肇丽梅,郭善斌.HPLC法测定血浆中奥美拉唑及其人体药动学研究[J].沈阳药科大学学报,2004,21(5):337-340. 被引量:10
  • 3胡玉荣,张楠,单丽红,田鑫,乔海灵.RP-HPLC法测定人血浆中奥美拉唑浓度及其在健康男性志愿者药代动力学研究[J].中国临床药理学与治疗学,2005,10(9):1065-1068. 被引量:5
  • 4田书霞,蒋晔,赵静,任进民,王淑梅.反相高效液相色谱法测定人体血浆中奥美拉唑含量[J].中国药业,2006,15(4):50-51. 被引量:3
  • 5Andersson T.Pharmacokinetics,metabolism and interactions of acid pump inhibitors.Focus on omeprazole,lansoprazole and pantoprazole[J].Clin Pharmacokinet,1996(1):9-28.
  • 6Bertilsson L.Geographical/interracial differences in polymorphic drug oxidation.Current state of knowledge of cytochrommes P450 (CYP) 2D6 and 2C19[J].Clin Pharmacokinet,1995(3):192-209.
  • 7Karin Dilger,Zhichichang Zheng,Klotz U.Lack of drug interaction between omprazole,lansoprazole,pantazole and theophylline[J].Br J Chin Pharmacol,1999(3):438-444.
  • 8Rezk NL, Brown KC, Kashuba ADM. A simple and sensitive bioanalytieal assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP- HPLC after a simple liquid - liquid extraction procedure[J]. J Chromatogr B, 2006,844(2): 314 - 322.
  • 9Sluggett GW, Stong JD, Adams JH, et al. Omeprazole determination using HPLC with coulometric detection [ J ]. J Phann Biomed Anal,2001,25(3 - 4) : 357 - 361.
  • 10Kanazawa H, Okada A, Matsushima Y, et al. Determination of omeprazole and its metabolites in human plasma by liquid chromatography- mass spectrometry [ J ]. J Chromatogr A, 2002, 949(1-2): 1-9.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部